329 related articles for article (PubMed ID: 11904440)
1. Deficient Smad7 expression: a putative molecular defect in scleroderma.
Dong C; Zhu S; Wang T; Yoon W; Li Z; Alvarez RJ; ten Dijke P; White B; Wigley FM; Goldschmidt-Clermont PJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3908-13. PubMed ID: 11904440
[TBL] [Abstract][Full Text] [Related]
2. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
4. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.
Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
J Clin Invest; 2004 Jan; 113(2):253-64. PubMed ID: 14722617
[TBL] [Abstract][Full Text] [Related]
5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
6. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
[TBL] [Abstract][Full Text] [Related]
8. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
Mori Y; Chen SJ; Varga J
Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
[TBL] [Abstract][Full Text] [Related]
9. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
10. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach.
Verrecchia F; Chu ML; Mauviel A
J Biol Chem; 2001 May; 276(20):17058-62. PubMed ID: 11279127
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
Denissova NG; Pouponnot C; Long J; He D; Liu F
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6397-402. PubMed ID: 10823886
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts.
Kopp J; Preis E; Said H; Hafemann B; Wickert L; Gressner AM; Pallua N; Dooley S
J Biol Chem; 2005 Jun; 280(22):21570-6. PubMed ID: 15788410
[TBL] [Abstract][Full Text] [Related]
17. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-beta signaling.
Zhao Y; Geverd DA
Biochem Biophys Res Commun; 2002 Jun; 294(2):319-23. PubMed ID: 12051713
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
20. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity.
Wu D; Luo S; Wang Y; Zhuang L; Chen Y; Peng C
Mol Cell Endocrinol; 2001 Apr; 175(1-2):111-21. PubMed ID: 11325521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
